In addition, the development of diabetic retinopathy was reported to be triggered by increased serum plasminogen activator inhibitor-1 (PAI-1) and soluble endothelial leukocyte adhesion molecule-1 (sE-selectin) levels [33]. This evidence concerns the gene SELE and diabetic retinopathy.